Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Lifting of restriction Bill

I agree that a better answer is needed. What made this qtr. worthy of an insider trading ban any different from previous quarters? With what seems to be disclosure of only lower than expected earnings numbers, a lifting of the ban would suggest that there is nothing further to be gained from the J's or any of the other companies.

Certainly knowing that royalties will be paid or that payment depends on USPTO decision would still be material and the ban would be kept in place until shareholders were informed.

 

Share
New Message
Please login to post a reply